Phase 3 PEACHTREE, AZALEA integrated study results: BCVA gains, CST reduction associated with suprachoirodal injection
May 11, 2022
The Phase 3 integrated PEACHTREE and AZALEA study data revealed strong safety and efficacy for triamcinolone acetonide via suprachoirodal injection.